Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical–or bioequivalent–to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies.
This report contains market size and forecasts of Inhalation & Nasal Spray Generic Drugs in global, including the following market information:
Global Inhalation & Nasal Spray Generic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inhalation & Nasal Spray Generic Drugs Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Inhalation & Nasal Spray Generic Drugs companies in 2021 (%)
The global Inhalation & Nasal Spray Generic Drugs market was valued at 10220 million in 2021 and is projected to reach US$ 14540 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inhalation & Nasal Spray Generic Drugs include Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy) and Nephron Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inhalation & Nasal Spray Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhalation & Nasal Spray Generic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Inhalation & Nasal Spray Generic Drugs Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Bronchodilators
Combinations
Decongestant Sprays
Others
Global Inhalation & Nasal Spray Generic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Inhalation & Nasal Spray Generic Drugs Market Segment Percentages, by Application, 2021 (%)
Asthma
COPD
Allergic Rhinitis
Others
Global Inhalation & Nasal Spray Generic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Inhalation & Nasal Spray Generic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhalation & Nasal Spray Generic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inhalation & Nasal Spray Generic Drugs revenues share in global market, 2021 (%)
Key companies Inhalation & Nasal Spray Generic Drugs sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Inhalation & Nasal Spray Generic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Sandoz (Novartis AG)
Mylan
Allergan PLC
Cipla
Akorn
Apotex
Sun Pharma (Ranbaxy)
Nephron Pharma
Beximco Pharma
Hikma (Roxane)
XIANJU PHARMA

LEAVE A REPLY

Please enter your comment!
Please enter your name here